Population pharmacokinetic analysis of ledipasvir in patients with decompensated cirrhosis - results from the UK Expanded Access programme.

导出原文传递

翻译打印收藏纠错

作者： El-Sherif, Omar ^[1] ; Pertinez, Henry ^[2] ; Irving, William ^[3] ; Penchala, Sujan Dilly ^[4] ; McLauchlan, John ^[5] ; Foster, Graham R. ; Norris, Suzanne ; Else, Laura ; Khoo, Saye

作者单位： Queen Mary Univ London, London, England ^[1] Univ Nottingham, Nottingham, England ^[2] Univ Liverpool, Liverpool, Merseyside, England ^[3] Univ Glasgow, Glasgow, Lanark, Scotland ^[4] St James Hosp, Dept Hepatol, Dublin, Ireland ^[5]

发布时间 2020-08-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Hepatology

2017年66卷Suppl.1期

831A-832A页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Population pharmacokinetic analysis of ledipasvir in patients with decompensated cirrhosis - results from the UK Expanded Access programme.

Hepatology

相似文献

Hepatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Population pharmacokinetic analysis of ledipasvir in patients with decompensated cirrhosis - results from the UK Expanded Access programme.

Hepatology

相似文献

Hepatology

相关期刊

检索历史清除